working groups

ENS@T operates in four core Working Groups

ACC Working Group

Felix Beuschlein, MD
Endocrine Research Unit
Medizinische Klinik und Poliklinik IV
University Hospital Munich
Ziemssenstr. 1
Munich, Germany

Felix Beuschlein is Professor of Internal Medicine/Endocrinology, Head of the Endocrine Research Unit and runs the Endocrine Outpatient Clinic at the University Hospital in Munich. His main scientific interest pertain to all fields of adrenal research including adrenocortical carcinoma, primary aldosteronism, Cushing’s syndrome and pheochromocytoma. He has served as the chairman of ENSAT between 2008 and 2016 and has led an FP7 funded consortium on adrenal tumors (ENSAT-CANCER).

Period in office: 2016-2019

Scientific Board:
Martin Fassnacht, Würzburg, Germany
Guillaume Assie, Paris, France
Alfredo Berruti, Brescia, Italy
Peter Igaz, Budapest, Hungary

period in office: 2015-2018



Pheo/PPGL Working Group

Mercedes Robledo, PhD
Hereditary Endocrine Cancer, Group Leader
Human Cancer Genetics Programme
Spanish National Cancer Centre (CNIO)
C/ Melchor Fernández Almagro 3
Madrid, Spain

Mercedes Robledo is the head of the Hereditary Endocrine Cancer Group, in the Human Genetics Cancer Program at the Spanish National Cancer Center (CNIO), Madrid, Spain. Her Group is interested in identifying high and low genetic risk factors involved in pheochromocytoma and thyroid cancer susceptibility. To this end, we analyse tumour samples and look for differences between genomic features according to the different individual genetic backgrounds. Such comprehensive characterisation allows us, not only to define diagnostic and prognostic markers associated with primary mutations, but also to pinpoint specific altered pathways that can lead to the identification of future therapeutic targets.

Period in office: 2017-2020

Scientific Board:
Henri Timmers, Nijmegen, The Netherlands
Judith Favier, Paris, France
Anne-Paule Gimenez-Roqueplo, Paris, France
Elena Rapizzi, Florence, Italy
Rodrigo Toledo, Barcelona, Spain

period in office: 2017-2020


APA Working Group

Martin Reincke, MD

Medizinische Klinik und Poliklinik IV
University Hospital Munich
Ziemssenstr. 1
Munich, Germany

Martin Heinrich Reincke is the director of the Medizinische Klinik and Poliklinik IV, Ludwig-Maximilians University in Munich and Chair of the Department of Endocrinology and Diabetology..

His research focus includes adrenal physiology and pathophysiology, endocrine hypertension, pituitary disease, mineralocorticoid and glucocorticoid action and stress research. Professor Reincke is heading a research team specifically exploring the prevalence and relevance of mineralocorticoid excess in resistant hypertension on the epidemiological, clinical, genetic and molecular level.

Professor Reincke is a member of many national and international societies, including the Endocrine Society, European Society of Endocrinology and European Network of the study of adrenal tumors. He has served in the Executive Board of the German Endocrine Society and European Society of Endocrinology, is on the editorial board of several international journals, and has served as teaching dean of the faculty from 2006-2012.

He has published more than 380 Medline listed publications cited >9200 times, his h-index is 53.

Period in office: 2017-2020

Scientific Board:
Marcus Quinkler, Berlin, Germany
Tracy Williams, Torino, Italy
Jacques Lenders, Nijmegen, The Netherlands
Mitsuhide Naruse, Kyoto, Japan
Aleksander Prejbisz, Warsaw, Poland

period in office: 2017-2020


NAPACA Working Group

Wiebke Arlt, MD, DSc., FRCP, FMedSci
Institute of Metabolism and Systems Research (IMSR)
University of Birmingham
& Centre for Endocrinology, Diabetes and Metabolism (CEDAM)
Birmingham Health Partners
Birmingham, UK

Professor Wiebke Arlt is William Withering Chair of Medicine and Director of the Institute of Metabolism and Systems Research at the University of Birmingham, UK. She leads a multi-disciplinary research group focussing on steroid endocrinology in the context of adrenal and gonadal disorders. She is a Consultant Endocrinologist at the Queen Elizabeth Hospital Birmingham, where she serves as the Lead of the Adrenal Tumour Specialist Service. Her main interests are adrenal incidentaloma, adrenocortical carcinoma and adrenal steroid excess syndromes.

Period in office: 2017-2020

Scientific Board:
Felix Beuschlein, Munich, Germany
Iacopo Chiodini, Milan, Italy
Cristina Ronchi, Würzburg, Germany
Antoine Tabarin, Bordeaux, France

period in office: 2015-2018